Filariasis in India

Filariasis in India mind map
Recent News
India's elimination goal
By 2027
When
National Filaria Control Programme
Since 1955
Mass Drug Administration (MDA)
Started in 1996-1997
Why
Major public health issue
Caused by
Round, coiled, thread-like parasitic worms
What
Lymphatic Filariasis (LF)
Commonly known as Elephantiasis
Causing organisms
Wuchereria bancrofti, Brugia malayi
Transmission
Through mosquitoes
National Health Policy
Goal set in 2002
Extended to 2021
Global Alliance to Eliminate Lymphatic Filariasis
Formed in 2000
Drugs used
Diethylcarbamazine (DEC)
Albendazole
Where
Endemic areas
Across 21 states, union territories
Major states affected
Uttar Pradesh, Odisha, Telangana, Bihar
Who
Over 650 million at risk
In India
Significance in global context
More than 40% of worldwide cases
How
Strategies
Mass drug administration
Vector control
Challenges
Coverage in urban areas
Socio-economic impacts
Significance
Reducing disability
Preventing social, economic insecurity
Challenges
Infection risk in childhood
Hidden damage to lymphatic system
Socio-economic conditions impact
Way Forward
Targeted strategies
For high-risk areas
Enhanced five-pronged strategy
For elimination

Filariasis in India is a significant public health issue, primarily caused by parasitic worms transmitted through mosquitoes. Efforts to eliminate this disease, commonly known as Elephantiasis, have been ongoing since 1955 with the National Filaria Control Programme. The Indian government aims to eliminate Lymphatic Filariasis by 2027, using strategies like mass drug administration and vector control. Major challenges include the disease’s prevalence in 21 states and territories and its socio-economic impact. The way forward involves targeted approaches in high-risk areas and an enhanced strategy for elimination.